Search
Patexia Research
Case number 1:20-cv-01365

Otsuka Pharmaceutical Co., Ltd. et al v. Alembic Pharmaceuticals Ltd. et al > Documents

Date Field Doc. No.Description (Pages)
May 19, 2022 N/A Terminated Case (0)
Docket Text: CASE CLOSED (See D.I. 510 in lead case no. 19-1938-LPS) Associated Cases: 1:19-cv-02007-LPS, 1:20-cv-01365-LPS (ntl)
May 19, 2022 16 Patent/Trademark Report to Commissioner (3)
Docket Text: Report to the Commissioner of Patents and Trademarks. (ntl)
Jun 21, 2021 N/A SO ORDERED (0)
Docket Text: SO ORDERED, re (97 in 1:19-cv-01938-LPS, 15 in 1:20-cv-01365-LPS) STIPULATION Regarding Partial Dismissal of Claims and Counterclaims, and Regarding Consolidation. Signed by Judge Leonard P. Stark on 6/21/21. Associated Cases: 1:19-cv-01938-LPS, 1:20-cv-01365-LPS (ntl)
Jun 21, 2021 N/A Create Case Association (0)
Docket Text: Case associated with lead case: Create association to 1:19-cv-01938-LPS. (ntl)
Jun 16, 2021 15 Stipulation (5)
Docket Text: STIPULATION Regarding Partial Dismissal of Claims and Counterclaims, and Regarding Consolidation (Alembic Pharmaceuticals Ltd., et al.), by Otsuka Pharmaceutical Co., Ltd., H. Lundbeck A/S. (Balick, Steven)
Jan 14, 2021 N/A Add Attorneys Pro Hac Vice (0)
Docket Text: Pro Hac Vice Attorneys Denise Main, Erin M. Sommers, C. Collette Corser, Tyler B. Latcham for H. Lundbeck A/S and Otsuka Pharmaceutical Co., Ltd. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. Associated Cases: 1:20-cv-01287-LPS et al.(kmd)
Jan 5, 2021 N/A SO ORDERED (0)
Docket Text: SO ORDERED, re (14 in 1:20-cv-01365-LPS, 8 in 1:20-cv-01287-LPS, 13 in 1:20-cv-01296-LPS, 9 in 1:20-cv-01599-LPS, 7 in 1:20-cv-01428-LPS, 12 in 1:20-cv-01423-LPS, 11 in 1:20-cv-01335-LPS, 10 in 1:20-cv-01295-LPS, 7 in 1:20-cv-01581-LPS, 7 in 1:20-cv-01502-LPS, 7 in 1:20-cv-01763-LPS, 10 in 1:20-cv-01297-LPS, 11 in 1:20-cv-01332-LPS, 13 in 1:20-cv-01531-LPS) MOTION for Pro Hac Vice Appearance of Attorney James B. Monroe, Denise Main, Erin M. Sommers, C. Collette Corser and Tyler B. Latcham filed by Otsuka Pharmaceutical Co.,Ltd, Otsuka Pharmaceutical Co., Ltd., H. Lundbeck A/S, Otsuka Pharmaceutical Co. Ltd., H. Lundbeck A/S. Signed by Judge Leonard P. Stark on 1/5/21. Associated Cases: 1:20-cv-01287-LPS et al. (ntl)
Dec 31, 2020 14 Motion for Leave to Appear Pro Hac Vice (17)
Docket Text: MOTION for Pro Hac Vice Appearance of Attorney James B. Monroe, Denise Main, Erin M. Sommers, C. Collette Corser and Tyler B. Latcham - filed by H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd., Otsuka Pharmaceutical Co.,Ltd, Otsuka Pharmaceutical Co. Ltd., H. Lundbeck A/S. (Mayo, Andrew)
Nov 25, 2020 13 Answer to Counterclaim (9)
Docket Text: ANSWER to [9] Answer to Complaint,, Counterclaim, by H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd..(Balick, Steven)
Nov 18, 2020 N/A Add Attorneys Pro Hac Vice (0)
Docket Text: Pro Hac Vice Attorney Robert Stout,Dennies Varughese for Alembic Pharmaceuticals Ltd. and Alembic Pharmaceuticals, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (mal)
Nov 17, 2020 N/A SO ORDERED (0)
Docket Text: SO ORDERED, re [12] MOTION for Pro Hac Vice Appearance of Attorney Dennies Varughese and Robert W. Stout filed by Alembic Pharmaceuticals Ltd., Alembic Pharmaceuticals, Inc. Signed by Judge Leonard P. Stark on 11/17/20. (ntl)
Nov 12, 2020 12 Motion for Leave to Appear Pro Hac Vice (4)
Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Dennies Varughese and Robert W. Stout - filed by Alembic Pharmaceuticals Ltd., Alembic Pharmaceuticals, Inc.. (Palapura, Bindu)
Nov 11, 2020 11 Main Document (25)
Docket Text: REDACTED VERSION of [9] Answer to Complaint,, Counterclaim, by Alembic Pharmaceuticals Ltd., Alembic Pharmaceuticals, Inc.. (Attachments: # (1) Exhibit 1)(Moore, David)
Nov 11, 2020 11 Exhibit 1 (2)
Nov 4, 2020 7 Waiver of Service Executed (1)
Docket Text: WAIVER OF SERVICE returned executed by Otsuka Pharmaceutical Co., Ltd., H. Lundbeck A/S : For Alembic Pharmaceuticals Ltd. waiver sent on 11/2/2020, answer due 2/1/2021. (Balick, Steven)
Nov 4, 2020 8 Waiver of Service Executed (1)
Docket Text: WAIVER OF SERVICE returned executed by Otsuka Pharmaceutical Co., Ltd., H. Lundbeck A/S : For Alembic Pharmaceuticals, Inc. waiver sent on 11/2/2020, answer due 1/1/2021. (Balick, Steven)
Nov 4, 2020 10 Disclosure Statement (2)
Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent none for Alembic Pharmaceuticals Ltd.; Corporate Parent Alembic Global Holdings SA for Alembic Pharmaceuticals, Inc. filed by Alembic Pharmaceuticals Ltd., Alembic Pharmaceuticals, Inc.. (Moore, David)
Oct 14, 2020 N/A Case Assigned/Reassigned (0)
Docket Text: Case Assigned to Judge Leonard P. Stark. Please include the initials of the Judge (LPS) after the case number on all documents filed. (rjb)
Oct 9, 2020 N/A No Summons Issued (0)
Docket Text: No Summons Issued. (sam)
Oct 8, 2020 1 Main Document (11)
Docket Text: COMPLAINT for PATENT INFRINGEMENT- filed against Alembic Pharmaceuticals Ltd., Alembic Pharmaceuticals, Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number ADEDC-3253416.) - filed by Otsuka Pharmaceutical Co., Ltd., H. Lundbeck A/S (Attachments: # (1) Exhibit A-B, # (2) Civil Cover Sheet)(sam)
Oct 8, 2020 1 Exhibit A-B (60)
Oct 8, 2020 1 Civil Cover Sheet (4)
Oct 8, 2020 2 Magistrate Consent Forms (3)
Docket Text: Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (sam)
Oct 8, 2020 3 ANDA Form (2)
Docket Text: Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: August 28, 2020. Date of Expiration of Patent: See Attached.Thirty Month Stay Deadline: 1/10/2023. (sam)
Oct 8, 2020 4 Patent/Trademark Report to Commissioner (1)
Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) US RE48,059. (sam)
Oct 8, 2020 5 Disclosure Statement (1)
Docket Text: Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by H. Lundbeck A/S. (sam)
Oct 8, 2020 6 Disclosure Statement (1)
Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Otsuka Holdings Co., Ltd. for Otsuka Pharmaceutical Co., Ltd. filed by Otsuka Pharmaceutical Co., Ltd. (sam)
Menu